EQUITY PURCHASE AGREEMENTEquity Purchase Agreement • October 10th, 2018 • Propanc Biopharma, Inc. • Pharmaceutical preparations • Kansas
THIS EQUITY PURCHASE AGREEMENT (this “Agreement”) is entered into as of October 5, 2018 (the “Execution Date”), by and between Propanc Biopharma, Inc., a Delaware corporation (the “Company”), and L2 Capital, LLC, a Kansas limited liability company (the “Investor”).
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • October 10th, 2018 • Propanc Biopharma, Inc. • Pharmaceutical preparations • Kansas
THIS REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of October 5, 2018 (the “Execution Date”), is entered into by and between PROPANC BIOPHARMA, INC., a Delaware corporation (the “Company”), and L2 CAPITAL, LLC, a Kansas limited liability company (together with its permitted assigns, the “Buyer”). Capitalized terms used herein and not otherwise defined herein shall have the respective meanings set forth in that certain Equity Purchase Agreement by and between the parties hereto, dated as of the Execution Date (as amended, restated, supplemented or otherwise modified from time to time, the “Purchase Agreement”).
